David H -f Teng

Title: David H-f Teng: Innovator in Human Genetics

Introduction

David H-f Teng is a notable inventor in the field of human genetics, based in Salt Lake City, Utah. He has made significant contributions to understanding genetic mutations associated with cancer. His work focuses on the CDC14A gene, which has implications for cancer diagnosis and therapy.

Latest Patents

David H-f Teng holds a patent related to the human CDC14A gene. This invention pertains to the identification of mutations in the CDC14A gene found in certain tumor cell lines. The patent outlines a novel sequence for the human CDC14A gene and discusses its relevance in diagnosing and prognosing human cancer. Furthermore, it explores therapeutic approaches for cancers with mutations in the CDC14A gene, including gene therapy, protein replacement therapy, and drug screening for cancer treatment.

Career Highlights

David H-f Teng is associated with Myriad Genetics, Inc., where he applies his expertise in genetics to advance cancer research. His work has contributed to the understanding of genetic predispositions to cancer, enhancing the potential for targeted therapies.

Collaborations

Some of his notable coworkers include Alexander K C Wong and Sean V Tavtigian, who collaborate with him in research and development efforts at Myriad Genetics, Inc.

Conclusion

David H-f Teng's innovative work in human genetics, particularly concerning the CDC14A gene, has the potential to transform cancer diagnosis and treatment. His contributions highlight the importance of genetic research in advancing medical science.